Robert Reid

679 total citations
12 papers, 487 citations indexed

About

Robert Reid is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert Reid has authored 12 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert Reid's work include Cancer Genomics and Diagnostics (5 papers), Molecular Biology Techniques and Applications (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Robert Reid is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Molecular Biology Techniques and Applications (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Robert Reid collaborates with scholars based in United States, United Kingdom and Canada. Robert Reid's co-authors include John Powe, D.G. McGowan, Kelvin Hong, Alexander McEwan, Karen Y. Gulenchyn, Juanita Crook, J. H. Yardley, Himu Lukka, Arthur T. Porter and Carl A. Wesolowski and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Robert Reid

10 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Reid United States	7	278	252	223	150	74	12	487
René Blom Sweden	8	416 1.5×	272 1.1×	358 1.6×	87 0.6×	58 0.8×	11	644
Ali Hasbini France	13	346 1.2×	137 0.5×	114 0.5×	104 0.7×	68 0.9×	47	502
C. Gillies O'Bryan-Tear United Kingdom	12	355 1.3×	197 0.8×	263 1.2×	61 0.4×	49 0.7×	23	471
Chris Bangma Netherlands	12	336 1.2×	105 0.4×	73 0.3×	122 0.8×	72 1.0×	28	547
Sofia C. Vaz Portugal	12	176 0.6×	95 0.4×	245 1.1×	61 0.4×	68 0.9×	36	429
Paolo Montemaggi Italy	11	256 0.9×	202 0.8×	76 0.3×	252 1.7×	67 0.9×	37	518
Khaldoun Kerrou France	11	111 0.4×	121 0.5×	159 0.7×	102 0.7×	87 1.2×	22	424
Günther Meisetschläger Germany	5	395 1.4×	149 0.6×	315 1.4×	345 2.3×	31 0.4×	7	667
Joachim Müller Switzerland	12	187 0.7×	159 0.6×	130 0.6×	44 0.3×	42 0.6×	23	393
Yasuhiro Sasakawa Japan	11	164 0.6×	132 0.5×	315 1.4×	104 0.7×	52 0.7×	19	525

Countries citing papers authored by Robert Reid

Since Specialization

Citations

This map shows the geographic impact of Robert Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Reid more than expected).

Fields of papers citing papers by Robert Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Reid. The network helps show where Robert Reid may publish in the future.

Co-authorship network of co-authors of Robert Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Reid. A scholar is included among the top collaborators of Robert Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Reid. Robert Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Marinac, Catherine R., Charles H. McDonnell, Lincoln Nadauld, et al.. (2025). Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study. Cancer Prevention Research. 18(8). 475–483.

Klein, Eric A., Charles H. McDonnell, Lincoln Nadauld, et al.. (2023). Clinical evaluation of cancer signal origin prediction and diagnostic resolution following multi-cancer early detection testing.. Journal of Clinical Oncology. 41(16_suppl). 10520–10520. 1 indexed citations

Reid, Robert, Traci Leong, Barbara Kunz, et al.. (2023). The impact of social determinants of health (SDOH) on use of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.. Journal of Clinical Oncology. 41(16_suppl). 1094–1094.

Reid, Robert, et al.. (2022). Real-world progression-free and overall survival for patients with advanced ovarian cancer utilizing PARP inhibitor second-line maintenance therapy vs active surveillance.. Journal of Clinical Oncology. 40(16_suppl). e18812–e18812. 3 indexed citations

Beer, Tomasz M., Charles H. McDonnell, Lincoln Nadauld, et al.. (2021). Interim results of PATHFINDER, a clinical use study using a methylation-based multi-cancer early detection test.. Journal of Clinical Oncology. 39(15_suppl). 3010–3010. 20 indexed citations

Beer, Tomasz M., Charles H. McDonnell, Lincoln Nadauld, et al.. (2021). A prespecified interim analysis of the PATHFINDER study: Performance of a multicancer early detection test in support of clinical implementation.. Journal of Clinical Oncology. 39(15_suppl). 3070–3070. 9 indexed citations

Carter, Dennis L., Lina Asmar, Mark Allen O’Rourke, et al.. (2008). Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma. Investigational New Drugs. 26(5). 473–481. 6 indexed citations

Senderowicz, Adrian M., Robert Reid, Donna Headlee, et al.. (1999). A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer. Urologia Internationalis. 63(2). 120–125. 11 indexed citations

Figg, William D., Alain Thibault, Michael R. Cooper, et al.. (1995). A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer. Cancer. 75(8). 2159–2164. 40 indexed citations

10.

Porter, Arthur T., Alexander McEwan, John Powe, et al.. (1993). Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 25(5). 805–813. 379 indexed citations

11.

Greig, Russell, et al.. (1985). Alterations in the phosphoprotein composition of tumor cell clones induced by cell culture techniques used routinely in assessing metastatic behavior in vivo. International Journal of Cancer. 35(3). 367–375. 3 indexed citations

12.

Greig, Russell, et al.. (1983). Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.. PubMed. 43(12 Pt 1). 6057–65. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact